DIETARY HIGH MOLECULAR WEIGHT FLAVANOLS  AS CARDIOPROTECTIVE ADJUVANTS IN TYPE 2 DIABETES FROM THEIR MOLECULAR MECHANISM TO THEIR PRE-CLINICAL AND CLINICAL EFFECTS